This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Innospec Board OKs Poison Pill

NEWARK, Del. (AP) ¿ Chemicals producer Innospec Inc. on Friday said its board approved a stockholder rights plan, often called a "poison pill," which is typically intended to protect a company from a hostile takeover bid.

Innospec said its plan "is designed to enable all Innospec stockholders to realize the full long-term value of their investment and to provide for fair and equal treatment for all stockholders in the event that an unsolicited attempt is made to acquire the company."

The chemicals industry has seen a handful of high-profile combinations in the past year, although the economic downturn has slowed activity.

Innospec said its board believes the value of its business is not reflected in the current market price of the company's stock, which may make it vulnerable to hostile takeover tactics.

Innospec shares closed at $10.65 Friday, up about 81 percent since the start of the year. closed 12/31 at $5.89 The stock traded as high as $32.45 two years ago, and in the past 52 weeks has moved between $2.61 and $24.06.

Innospec said its rights plan will protect shareholders against takeover tactics that may be used to gain control without paying a price in the best interest of investors.

In aftermarket electronic trading, Innospec shares slipped 17 cents to $10.48

Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
IOSP $44.85 1.50%
AAPL $129.78 1.00%
FB $79.60 0.80%
GOOG $562.08 0.66%
TSLA $197.62 -2.80%


DOW 18,246.15 +113.45 0.63%
S&P 500 2,112.51 +8.01 0.38%
NASDAQ 4,997.3610 +33.8340 0.68%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs